Novartis

UCB Signs Up To $1.5 Bln Deal With Novartis To Co-develop Two Parkinson's Disease Drugs
NASDAQ
Thu, 12/2/21 - 10:39 am
Novartis
UCB Pharma
drug development
Parkinson's Disease
Get ready for M&A: Large biopharma companies will have $1.7T in dealmaking firepower next year, analyst says
Fierce Pharma
Wed, 12/1/21 - 11:28 am
M&A
pharma industry
Big Pharma
JNJ
Pfizer
Moderna Therapeutics
Novartis
BioNTech
GSK
Spinoff updates: Merck’s Organon and Novartis’ Sandoz
Generics and Biosimilar Initiative
Mon, 11/29/21 - 11:08 pm
spinoffs
Merck
Organon
earnings
Novartis
Sandoz
biosimilars
Novartis plans unconventional sales strategy for new heart drug
Beckers Hospital Review
Mon, 11/22/21 - 10:29 pm
Novartis
pharma marketing
EHRs
Leqvio
EQT, Biontech investor family consider Sandoz bid
Yahoo/Reuters
Fri, 11/19/21 - 11:12 am
EQT
BioNTech
Sandoz
generics
Novartis
M&A
Where will Novartis spend the $21B from Roche stake sale? Alnylam buyout could be one: report
Fierce Pharma
Thu, 11/18/21 - 10:50 am
Novartis
Roche
M&A
Alnylam
Acelyrin raises $250M, licenses antibody drug that could rival Novartis, Lilly meds
MedCity News
Tue, 11/16/21 - 10:31 am
Acelyrin
Affibody
antibodies
monoclonal antibodies
immunology
Novartis
Eli Lilly
The quest for efficacy in pancreatic cancer
EP Vantage
Thu, 11/11/21 - 10:53 am
pancreatic cancer
Novartis
FibroGen
Tyme Technologies
Erytech
Rafeal Pharmaceuticals
Novartis dumps 2nd bispecific from $2.6B Xencor pact, dealing further blow to hopes for blood cancer target
Fierce Biotech
Tue, 11/9/21 - 10:40 am
Novartis
Xencor
bispecifics
blood cancers
Mixed court decisions for Novartis in DC and Sanofi, Novo Nordisk in NJ further complicate whose interpretation of 340B is correct
Endpoints
Mon, 11/8/21 - 10:46 am
legal
drug discounts
340B
Medicare
Sanofi
Novartis
Novo Nordisk
Swiss socialists say government should buy Sandoz
Pharmaforum
Mon, 11/8/21 - 10:38 am
Switzerland
Novartis
Sandoz
M&A
generics
Novartis’ iptacopan hits the mark in rare kidney disease C3G
Pharmaforum
Fri, 11/5/21 - 09:54 am
Novartis
iptacopan
C3G
kidney disease
What Novartis could buy with its windfall
EP Vantage
Fri, 11/5/21 - 09:40 am
Novartis
M&A
Roche
Sandoz
Aurinia Pharmaceuticals
Alnylam
Exelixis
Incyte
Eisai
Genmab
Novartis to sell its Roche stake for $20.7 billion
Axios
Thu, 11/4/21 - 10:54 am
Novartis
Roche
Novartis teams with advocacy group to bring visibility to atherosclerotic cardiovascular disease
Fierce Pharma
Wed, 11/3/21 - 10:36 am
Novartis
pharma marketing
patient advocacy groups
atherosclerosis
ASCVD
Novartis makes protein degrader play, inking deal with new British startup to access fruits of novel tech
Fierce Biotech
Tue, 11/2/21 - 10:53 am
Novartis
protein degradation
Dunad Therapeutics
biobucks
AbbVie, Janssen, Novartis, Pfizer and UCB to jointly advance 'digital' endpoint for atopic dermatitis
Endpoints
Tue, 11/2/21 - 10:48 am
atopic dermatitis
eczema
nocturnal scratch
digital endpoint
AbbVie
Janssen
JNJ
Novartis
Pfizer
UCB Pharma
digital pharma
FDA Approves Scemblix for Pretreated CML in the Chronic Phase
Cure Today
Sat, 10/30/21 - 10:46 pm
Novartis
Scemblix
FDA
CML
Novartis dumps Rett gene therapy caught up in Zolgensma scandal in cull of pipeline prospects
Fierce Biotech
Tue, 10/26/21 - 10:41 am
Novartis
Rett Syndrome
AVXS-201
Zolgensma
gene therapy
Novartis looking into future of its Sandoz’ generics business
Pharmaforum
Tue, 10/26/21 - 10:30 am
Novartis
generics
Sandoz

Pages